China National Chemical Engineering (601117) Fundamentals 2026 — P/E 7.1x, Revenue Analysis | SniperIQ
China National Chemical Engineering (601117) is a CN-listed Industrials company in Engineering & Construction with a market capitalization of ¥47.1B, trading at ¥7.71 on the SHH. This SniperIQ fundamentals page covers China National Chemical Engineering's valuation (P/E 7.1x, P/B 0.7x), profitability (net margin 3.4%), revenue (¥189.9B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is China National Chemical Engineering's market cap?
China National Chemical Engineering (601117) has a market capitalization of approximately ¥47.1B, trading at ¥7.71 on the SHH. Market cap moves with the live share price.
What is China National Chemical Engineering's P/E ratio?
China National Chemical Engineering's trailing twelve-month P/E ratio is 7.1x, with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is China National Chemical Engineering?
China National Chemical Engineering runs a net profit margin of 3.4%, a gross margin of 10.9%, and an operating margin of 4.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does China National Chemical Engineering generate?
China National Chemical Engineering reported revenue of ¥189.9B for fiscal year 2025, with net income of ¥6.4B and earnings per share (EPS) of 1.06. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does China National Chemical Engineering pay a dividend?
China National Chemical Engineering offers a trailing dividend yield of about 3.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is China National Chemical Engineering financially healthy?
China National Chemical Engineering carries a debt-to-equity ratio of 0.41x and a current ratio of 1.13x, with a market beta of 0.65. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is China National Chemical Engineering a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For China National Chemical Engineering (601117) the key facts are: market cap ¥47.1B, P/E 7.1x, revenue ¥189.9B, 52-week range 7.15-10.48. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track China National Chemical Engineering's full fundamentals live
Get China National Chemical Engineering's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.